Cytotoxic lesion of the splenium of the corpus callosum in a patient with EVALI

Mark D. Messina, Terry L. Levin, Einat Blumfield

Research output: Contribution to journalArticle

Abstract

Since first recognized in July 2019, numerous cases of a lung illness associated with electronic-cigarette use or vaping particularly tetrahydrocannabinol in adolescents and adults have been reported. As of January 2020, the Center for Disease Control has reported over 2500 cases of electronic-cigarette or vaping product use-associated lung injury (EVALI), including 60 deaths. Affected patients most commonly present with respiratory or gastrointestinal complaints although neurological symptoms including headache, confusion and lethargy have been reported. We present a new as yet unpublished finding in the brain of a previously healthy teenage boy with EVALI. Brain imaging may be warranted in this patient population.

Original languageEnglish (US)
Pages (from-to)73-76
Number of pages4
JournalClinical Imaging
Volume66
DOIs
StatePublished - Oct 2020

Keywords

  • Cytotoxic lesion
  • E-cigarette vaping associated lung injury
  • EVALI
  • Splenium corpus callosum

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Cytotoxic lesion of the splenium of the corpus callosum in a patient with EVALI'. Together they form a unique fingerprint.

  • Cite this